BVF PARTNERS L P/IL

Insider Reports History

Location
San Francisco, CA
Signature
BVF Partners L.P., By: BVF Inc., its general partner, By: /s/ Mark N. Lampert, President
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by BVF PARTNERS L P/IL:

Company Role Class Num Shares Value Price $ Report Date Ownership
MoonLake Immunotherapeutics Director, 10%+ Owner Class A Ordinary Shares, $0.0001 par value 1,287,768 $51,742,518 $40.18 05 Jun 2025 Direct
XOMA Royalty Corp 10%+ Owner Common Stock, $0.0075 par value per share 1,267,545 $34,350,469 $27.10 16 May 2025 Direct
XOMA Royalty Corp 10%+ Owner Series X Convertible Preferred Stock 772 $18,998,920 $24610.00 16 May 2025 Indirect
Kymera Therapeutics, Inc. Director, Other* Common Stock, $0.0001 par value 353,412 $15,550,128 $44.00 30 Jun 2025 Direct
Verastem, Inc. 10%+ Owner Common Stock 994,353 $10,888,165 $10.95 25 Jan 2022 Direct
XOMA Royalty Corp 10%+ Owner Series X Convertible Preferred Stock 412 $10,139,320 $24610.00 16 May 2025 Direct
Merus N.V. 10%+ Owner Common Shares, (euro)0.09 nominal value per share 232,747 $6,467,225 $27.79 08 Oct 2021 Direct
Eledon Pharmaceuticals, Inc. 10%+ Owner Pre-funded Warrants to Purchase Common Stock 838,507 $3,059,712 $3.65 29 Oct 2024 Direct
Third Harmonic Bio, Inc. Other* Common Stock 176,692 $2,526,696 $14.30 29 Oct 2024 Direct
Kymera Therapeutics, Inc. Director, Other* Pre-Funded Warrants to Purchase Common Stock 52,733 $1,696,420 $32.17 25 Jun 2025 Direct
Olema Pharmaceuticals, Inc. Director, Other* Common stock, $0.0001 par value 347,970 $1,600,662 $4.60 11 Jun 2025 Direct
Olema Pharmaceuticals, Inc. Director, Other* Pre-Funded Warrant 336,288 $1,546,924 $4.60 11 Jun 2025 Direct
4D Molecular Therapeutics, Inc. Other* Common Stock, $0.0001 par value 87,911 $1,435,587 $16.33 08 Nov 2024 Direct
Cullinan Oncology, Inc. 10%+ Owner Common Stock 64,161 $799,446 $12.46 19 Jan 2023 Direct
PIERIS PHARMACEUTICALS, INC. Other* Common Stock, $0.001 par value 38,961 $618,794 $15.88 13 Dec 2024 Direct
Eledon Pharmaceuticals, Inc. 10%+ Owner Common Stock, $0.001 par value 220,460 $572,513 $2.60 29 Oct 2024 Direct
Kymera Therapeutics, Inc. Director, Other* Stock Option (Right to Buy) 16,000 $514,720 $32.17 25 Jun 2025 Indirect
Olema Pharmaceuticals, Inc. Director, Other* Common stock, $0.0001 par value 99,556 $457,957 $4.60 11 Jun 2025 Indirect
MoonLake Immunotherapeutics Director, 10%+ Owner Option to Buy 6,682 $268,482 $40.18 05 Jun 2025 Indirect
Olema Pharmaceuticals, Inc. Director, Other* Stock Option (Right to buy) 24,150 $111,090 $4.60 11 Jun 2025 Indirect
CRESCENT BIOPHARMA, INC. 10%+ Owner Common Stock 62,383 $15,595 $0.2500 13 Jun 2025 Direct
Allakos Inc. 10%+ Owner Common Stock, $0.001 par value 0 $0 $0.3200 15 May 2025 Direct
ESSA Pharma Inc. 10%+ Owner Common Stock 0 $0 $0.2400 09 Oct 2025 Direct
Rain Oncology Inc. Director, Other* Common Stock, $0.001 par value 0 $0 $1.21 25 Jan 2024 Direct
Repare Therapeutics Inc. 10%+ Owner Common Shares, no par value 0 $0 $2.60 28 Jan 2026 Direct
MoonLake Immunotherapeutics Director, 10%+ Owner Class A Ordinary Shares, $0.0001 par value 1,420,317 06 Jun 2024 Direct
Structure Therapeutics Inc. 10%+ Owner Convertible Non-Voting Ordinary Shares 462,605 10 May 2023 Direct
Eledon Pharmaceuticals, Inc. 10%+ Owner Warrants to Purchase Common Stock 252,291 29 Oct 2024 Direct
4D Molecular Therapeutics, Inc. Other* Pre-Funded Warrant 240,000 08 Nov 2024 Direct
enGene Holdings Inc. 10%+ Owner Class A Common Shares 104,257 31 Oct 2023 Direct
Cullinan Oncology, Inc. 10%+ Owner Series A Convertible Preferred Stock 30,000 19 Jan 2023 Direct
CRESCENT BIOPHARMA, INC. 10%+ Owner Pre-Funded Warrants to Purchase Common Stock 25,944 13 Jun 2025 Direct
Eledon Pharmaceuticals, Inc. 10%+ Owner Series X1 Convertible Preferred 7,635 29 Oct 2024 Direct
Eledon Pharmaceuticals, Inc. 10%+ Owner Series X Convertible Preferred 346 29 Oct 2024 Direct
PIERIS PHARMACEUTICALS, INC. Other* Series B Convertible Preferred Stock, $0.001 par value 284 13 Dec 2024 Direct
PIERIS PHARMACEUTICALS, INC. Other* Series C Convertible Preferred Stock, $0.001 par value 265 13 Dec 2024 Direct
Eledon Pharmaceuticals, Inc. 10%+ Owner Warrants to Purchase Series X1 Convertible Preferred Stock 189 29 Oct 2024 Direct
PIERIS PHARMACEUTICALS, INC. Other* Series D Convertible Preferred Stock, $0.001 par value 163 13 Dec 2024 Direct
PIERIS PHARMACEUTICALS, INC. Other* Series E Convertible Preferred Stock, $0.001 par value 161 13 Dec 2024 Direct
PIERIS PHARMACEUTICALS, INC. Other* Series A Convertible Preferred Stock, $0.001 par value 85 13 Dec 2024 Direct
CTI BIOPHARMA CORP Director, Other*, 10%+ Owner Common Stock, par value $0.001 0 $9.10 26 Jun 2023 Direct
CTI BIOPHARMA CORP Director, Other*, 10%+ Owner Common Stock, par value $0.001 0 $9.10 26 Jun 2023 Indirect
CTI BIOPHARMA CORP Director, Other*, 10%+ Owner Series O Convertible Preferred Stock 0 09 Aug 2022 Direct
CTI BIOPHARMA CORP Director, Other*, 10%+ Owner Series O Convertible Preferred Stock 0 09 Aug 2022 Indirect
CTI BIOPHARMA CORP Director, Other*, 10%+ Owner Series X1 Convertible Preferred Stock 0 26 Jun 2023 Direct
CTI BIOPHARMA CORP Director, Other*, 10%+ Owner Series X Convertible Preferred Stock 0 26 Jun 2023 Direct
CTI BIOPHARMA CORP Director, Other*, 10%+ Owner Series X Convertible Preferred Stock 0 26 Jun 2023 Indirect
CTI BIOPHARMA CORP Director, Other*, 10%+ Owner Stock Option (Right to Buy) 0 26 Jun 2023 Indirect
ESSA Pharma Inc. 10%+ Owner Pre-funded Warrants 0 05 Aug 2025 Direct
POINT Biopharma Global Inc. Former 10% Owner Common Stock, $0.0001 par value 0 $12.45 18 Dec 2023 Direct
Rain Oncology Inc. Director, Other* Non-Voting Common Stock, $0.001 par value 0 25 Jan 2024 Direct
Rain Oncology Inc. Director, Other* Stock Option (Right to Buy) 0 26 Jan 2024 Indirect
Structure Therapeutics Inc. 10%+ Owner Ordinary Shares, $0.0001 par value per share 0 10 May 2023 Direct

Insider Reports Filed by BVF PARTNERS L P/IL

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RPTX Repare Therapeutics Inc. 28 Jan 2026 3 $0 4 10%+ Owner 30 Jan 2026, 18:44
EPIX ESSA Pharma Inc. 09 Oct 2025 3 $0 4 10%+ Owner 14 Oct 2025, 17:33
EPIX ESSA Pharma Inc. 05 Aug 2025 9 -$0.9524 4 10%+ Owner 07 Aug 2025, 16:36
KYMR Kymera Therapeutics, Inc. 25 Jun 2025 4 +$13,955,348 4 Director, Other* 01 Jul 2025, 18:41
GLYC GLYCOMIMETICS INC 13 Jun 2025 6 $0 4 10%+ Owner 17 Jun 2025, 18:53
OLMA Olema Pharmaceuticals, Inc. 11 Jun 2025 1 $0 4 Director, Other* 13 Jun 2025, 18:23
MLTX MoonLake Immunotherapeutics 05 Jun 2025 1 $0 4 Director, 10%+ Owner 09 Jun 2025, 19:16
XOMA XOMA Royalty Corp 16 May 2025 2 -$10,642,793 4 10%+ Owner 20 May 2025, 18:56
ALLK Allakos Inc. 15 May 2025 3 $0 4 10%+ Owner 19 May 2025, 18:45
XOMA XOMA Royalty Corp 24 Jan 2025 4 -$16,983,714 4 10%+ Owner 28 Jan 2025, 17:23
OLMA Olema Pharmaceuticals, Inc. 10 Jan 2025 6 $0 4 Director, Other* 14 Jan 2025, 18:38
PVLA PALVELLA THERAPEUTICS, INC. 13 Dec 2024 3 $0 4 Other* 17 Dec 2024, 17:44
OLMA Olema Pharmaceuticals, Inc. 04 Dec 2024 9 +$22,383,570 4 Director, Other* 04 Dec 2024, 19:55
FDMT 4D Molecular Therapeutics, Inc. 08 Nov 2024 6 $0 4 Other* 13 Nov 2024, 16:33
THRD Third Harmonic Bio, Inc. 29 Oct 2024 3 -$14,300,000 4 Other* 31 Oct 2024, 17:53
ELDN Eledon Pharmaceuticals, Inc. 29 Oct 2024 3 +$17,349,349 4 10%+ Owner 31 Oct 2024, 17:52
MLTX MoonLake Immunotherapeutics 04 Oct 2024 3 -$100,003,200 4 Director, 10%+ Owner 08 Oct 2024, 18:50
KYMR Kymera Therapeutics, Inc. 20 Aug 2024 2 +$14,600,200 4 Director, Other* 22 Aug 2024, 17:06
FDMT 4D Molecular Therapeutics, Inc. 22 Jul 2024 0 $0 3 10%+ Owner 01 Aug 2024, 16:06
KYMR Kymera Therapeutics, Inc. 18 Jun 2024 1 $0 4 Director, Other* 28 Jun 2024, 17:05
OLMA Olema Pharmaceuticals, Inc. 14 Jun 2024 1 $0 4 Director, 10%+ Owner 18 Jun 2024, 17:31
MLTX MoonLake Immunotherapeutics 06 Jun 2024 1 $0 4 Director, 10%+ Owner 10 Jun 2024, 17:06
ELDN Eledon Pharmaceuticals, Inc. 09 May 2024 6 $0 4 10%+ Owner 13 May 2024, 17:04
/report/000119380524000107-bvf-partners-l-p-il-2024-01-25 Rain Oncology Inc. 25 Jan 2024 8 $0 4 Director, Other* 29 Jan 2024, 20:40
ALLK Allakos Inc. 16 Jan 2024 0 $0 3 10%+ Owner 26 Jan 2024, 17:15
KYMR Kymera Therapeutics, Inc. 05 Jan 2024 3 +$24,720,006 4 Director, Other* 09 Jan 2024, 16:49
/report/000119380523001635-bvf-partners-l-p-il-2023-12-18 POINT Biopharma Global Inc. 18 Dec 2023 3 -$213,657,911 4 Former 10% Owner 20 Dec 2023, 18:09
RPTX Repare Therapeutics Inc. 15 Nov 2023 6 +$6,249,889 4 10%+ Owner 17 Nov 2023, 16:54
KYMR Kymera Therapeutics, Inc. 02 Nov 2023 6 +$5,301,325 4 Director, Other* 06 Nov 2023, 18:07
/report/000092189523002467-bvf-partners-l-p-il-2023-11-02 POINT Biopharma Global Inc. 02 Nov 2023 0 $0 3 10%+ Owner 06 Nov 2023, 15:35
RPTX Repare Therapeutics Inc. 02 Nov 2023 3 +$2,821,352 4 10%+ Owner 03 Nov 2023, 17:37
ENGN enGene Holdings Inc. 31 Oct 2023 0 $0 3 10%+ Owner 13 Nov 2023, 16:48
OLMA Olema Pharmaceuticals, Inc. 12 Sep 2023 4 +$14,818,371 4 Director, 10%+ Owner 14 Sep 2023, 17:25
/report/000092189523001602-bvf-partners-l-p-il-2023-06-26 CTI BIOPHARMA CORP 26 Jun 2023 18 -$80,591,056 4 Director, Other*, 10%+ Owner 28 Jun 2023, 18:26
OLMA Olema Pharmaceuticals, Inc. 16 Jun 2023 1 $0 4 Director, 10%+ Owner 21 Jun 2023, 19:14
KYMR Kymera Therapeutics, Inc. 15 Jun 2023 1 $0 4 Director, Other* 20 Jun 2023, 17:55
MLTX MoonLake Immunotherapeutics 08 Jun 2023 1 $0 4 Director, 10%+ Owner 12 Jun 2023, 21:11
XOMA XOMA Corp 17 May 2023 1 $0 4 Director, Other*, 10%+ Owner 19 May 2023, 17:03
PVLA PIERIS PHARMACEUTICALS, INC. 11 May 2023 0 $0 3 10%+ Owner 22 May 2023, 17:00
GPCR Structure Therapeutics Inc. 10 May 2023 6 $0 4 10%+ Owner 12 May 2023, 20:00
ELDN Eledon Pharmaceuticals, Inc. 05 May 2023 9 $0 4 10%+ Owner 09 May 2023, 20:25
/report/000092189523000858-bvf-partners-l-p-il-2023-04-05 CTI BIOPHARMA CORP 05 Apr 2023 1 $0 4 Director, Other*, 10%+ Owner 07 Apr 2023, 17:00
GPCR Structure Therapeutics Inc. 03 Feb 2023 0 $0 3 10%+ Owner 13 Feb 2023, 19:05
CGEM Cullinan Oncology, Inc. 19 Jan 2023 6 $0 4 10%+ Owner 19 Jan 2023, 17:30
KYMR Kymera Therapeutics, Inc. 11 Jan 2023 4 +$1,251,191 4 Director, Other* 13 Jan 2023, 16:08
XOMA XOMA Corp 05 Jan 2023 4 +$420,737 4 Director, Other*, 10%+ Owner 09 Jan 2023, 16:44
THRD Third Harmonic Bio, Inc. 20 Dec 2022 3 +$879,499 4 10%+ Owner 22 Dec 2022, 17:49
THRD Third Harmonic Bio, Inc. 19 Dec 2022 0 $0 3 10%+ Owner 22 Dec 2022, 17:47
/report/000092189522002972-bvf-partners-l-p-il-2022-11-08 Rain Therapeutics Inc. 08 Nov 2022 3 +$9,971,387 4 Director, Other*, 10%+ Owner 10 Nov 2022, 17:31
XOMA XOMA Corp 23 Sep 2022 6 +$409,309 4 Director, Other*, 10%+ Owner 27 Sep 2022, 19:22
XOMA XOMA Corp 14 Sep 2022 4 +$990,718 4 Director, Other*, 10%+ Owner 16 Sep 2022, 18:30
KYMR Kymera Therapeutics, Inc. 22 Aug 2022 3 +$14,183,650 4 Director, Other* 23 Aug 2022, 17:35
/report/000092189522002404-bvf-partners-l-p-il-2022-08-09 CTI BIOPHARMA CORP 09 Aug 2022 12 -$52,020,000 4 Director, Other*, 10%+ Owner 11 Aug 2022, 17:52
EPIX ESSA Pharma Inc. 11 Jul 2022 0 $0 3 10%+ Owner 21 Jul 2022, 19:26
FDMT 4D Molecular Therapeutics, Inc. 16 Jun 2022 0 $0 3 10%+ Owner 27 Jun 2022, 17:38
KYMR Kymera Therapeutics, Inc. 15 Jun 2022 1 $0 4 Director, Other* 17 Jun 2022, 19:20
RPTX Repare Therapeutics Inc. 13 Jun 2022 3 +$1,898,820 4 10%+ Owner 15 Jun 2022, 18:15
OLMA Olema Pharmaceuticals, Inc. 10 Jun 2022 2 +$806,900 4 Director, 10%+ Owner 14 Jun 2022, 16:46
RPTX Repare Therapeutics Inc. 02 Jun 2022 9 +$21,859,329 4 10%+ Owner 06 Jun 2022, 18:14
CGEM Cullinan Oncology, Inc. 01 Jun 2022 3 +$8,264,905 4 10%+ Owner 03 Jun 2022, 18:24
KYMR Kymera Therapeutics, Inc. 26 May 2022 6 +$4,150,321 4 Director, Other* 31 May 2022, 19:50
KYMR Kymera Therapeutics, Inc. 20 May 2022 3 +$141,394 4 Director, Other* 24 May 2022, 20:09
XOMA XOMA Corp 18 May 2022 1 $0 4 Director, Other*, 10%+ Owner 20 May 2022, 19:18
RPTX Repare Therapeutics Inc. 18 May 2022 3 +$3,570,000 4 10%+ Owner 20 May 2022, 18:09
CGEM Cullinan Oncology, Inc. 12 May 2022 5 +$10,063,936 4 10%+ Owner 16 May 2022, 19:34
KYMR Kymera Therapeutics, Inc. 05 May 2022 6 +$4,865,365 4 Director, Other* 09 May 2022, 19:20
MLTX MoonLake Immunotherapeutics 05 Apr 2022 0 $0 3 Director, 10%+ Owner 15 Apr 2022, 17:26
CGEM Cullinan Oncology, Inc. 01 Apr 2022 2 +$2,966,972 4 10%+ Owner 05 Apr 2022, 18:45
/report/000119380522000486-bvf-partners-l-p-il-2022-03-09 CTI BIOPHARMA CORP 09 Mar 2022 1 $0 4 Director, Other*, 10%+ Owner 11 Mar 2022, 20:03
KYMR Kymera Therapeutics, Inc. 27 Jan 2022 4 +$5,076,473 4 Director, Other* 31 Jan 2022, 18:44
VSTM Verastem, Inc. 25 Jan 2022 0 $0 3 10%+ Owner 07 Feb 2022, 19:23
KYMR Kymera Therapeutics, Inc. 24 Jan 2022 2 +$10,300,637 4 Director, Other* 26 Jan 2022, 18:43
ELDN Eledon Pharmaceuticals, Inc. 20 Jan 2022 0 $0 3 10%+ Owner 31 Jan 2022, 19:52
RPTX Repare Therapeutics Inc. 19 Jan 2022 3 +$14,071,250 4 10%+ Owner 21 Jan 2022, 16:12
/report/000092189522000118-bvf-partners-l-p-il-2022-01-06 Rain Therapeutics Inc. 06 Jan 2022 4 +$6,692,638 4 Director, Other*, 10%+ Owner 10 Jan 2022, 17:03
CGEM Cullinan Oncology, Inc. 31 Dec 2021 0 $0 3 10%+ Owner 10 Jan 2022, 16:40
OLMA Olema Pharmaceuticals, Inc. 30 Nov 2021 3 +$6,945,770 4 Director, 10%+ Owner 02 Dec 2021, 19:45
RPTX Repare Therapeutics Inc. 28 Oct 2021 0 $0 3 10%+ Owner 08 Nov 2021, 17:12
MRUS Merus N.V. 07 Oct 2021 6 -$31,222,474 4 10%+ Owner 08 Oct 2021, 21:24
/report/000092189521002316-bvf-partners-l-p-il-2021-09-21 Rain Therapeutics Inc. 21 Sep 2021 3 +$153,829 4 Director, Other*, 10%+ Owner 23 Sep 2021, 20:05
/report/000092189521002289-bvf-partners-l-p-il-2021-09-13 Rain Therapeutics Inc. 13 Sep 2021 3 +$6,468,516 4 Director, Other*, 10%+ Owner 15 Sep 2021, 17:23
MRUS Merus N.V. 02 Jul 2021 3 -$45,359,956 4 10%+ Owner 07 Jul 2021, 16:49
/report/000092189521001798-bvf-partners-l-p-il-2021-07-01 Rain Therapeutics Inc. 01 Jul 2021 6 +$9,078,692 4 Director, Other*, 10%+ Owner 06 Jul 2021, 19:34
KYMR Kymera Therapeutics, Inc. 01 Jul 2021 3 +$25,575,802 4 Director, Other* 06 Jul 2021, 18:40
KYMR Kymera Therapeutics, Inc. 16 Jun 2021 1 $0 4 Director, Other* 21 Jun 2021, 16:19
/report/000092189521001493-bvf-partners-l-p-il-2021-05-21 Rain Therapeutics Inc. 21 May 2021 6 +$1,966,334 4 Director, Other*, 10%+ Owner 25 May 2021, 20:31
XOMA XOMA Corp 19 May 2021 1 $0 4 Director, Other*, 10%+ Owner 21 May 2021, 18:48
/report/000092189521001442-bvf-partners-l-p-il-2021-05-18 Rain Therapeutics Inc. 18 May 2021 6 +$3,457,720 4 Director, Other* 20 May 2021, 19:18
/report/000092189521001391-bvf-partners-l-p-il-2021-05-13 Rain Therapeutics Inc. 13 May 2021 3 +$827,167 4 Director, Other* 17 May 2021, 20:43
/report/000092189521001390-bvf-partners-l-p-il-2021-04-23-restatement Rain Therapeutics Inc. 23 Apr 2021 9 +$19,103,380 4/A Director, Other* 17 May 2021, 20:39
OLMA Olema Pharmaceuticals, Inc. 31 Mar 2021 1 $0 4 Director, 10%+ Owner 26 May 2021, 21:37